Efficacy Transverse Abdominal Plane (TAP) Block Renal Transplant Surgery
Unknown statusNot applicableNCT03181438
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The objective of this study is to evaluate the efficacy and safety of transverse abdominal plane block in patients undergoing renal transplant surgery.Adult renal transplant recipients will be prospectively randomized to receive a standard general anesthetic technique supplemented with ropivacaine 0.375% 20 mL TAP block or sham block with 20 mL 0.9% saline. Both groups will receive patient-controlled morphine analgesia. Patient assessment will occur in the postanesthetic care unit and at 1, 2, 4, 6, 12, and 24 hours. The primary outcome is total morphine consumption in the first 24 hours after renal transplantation. Other outcomes asses include pain scores, presence of nausea or vomiting, excessive sedation, and respiratory depression.
Study details
- Official title
- Efficacy of Ultrasound-guided Transverse Abdominal Plane Block for Analgesia in Renal Transplantation
- Conditions
- Renal Insufficiency, Chronic
- Acute Pain
- Kidney Transplantation
- Anesthesia, Conduction
- Interventions
- Procedure: TAP Block
- Procedure: Saline Group
- Sponsor
- Federal University of São Paulo
- Start date
- 2017-06-03
- Primary completion
- 2017-09
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Brazil
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * end-stage renal disease undergoing cadaveric renal transplantation Exclusion Criteria: * Contraindications to the use of morphine * Contraindications to the use ropivacaine * Peripheral neuropathy * Inability to use a Patient Control Analgesia device
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03181438